Acetaminophen
ApprovedWithdrawn 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acetaminophen Exposure
Conditions
Acetaminophen Exposure
Trial Timeline
Aug 1, 2021 → Aug 1, 2021
NCT ID
NCT02911961About Acetaminophen
Acetaminophen is a approved stage product being developed by Johnson & Johnson for Acetaminophen Exposure. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT02911961. Target conditions include Acetaminophen Exposure.
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00261560 | Approved | Completed |
| NCT06658574 | Phase 2 | Recruiting |
| NCT02911961 | Approved | Withdrawn |
Competing Products
1 competing product in Acetaminophen Exposure
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Intravenous infusion of N-acetylcysteine + Intravenous infusion of Fomepizole (4-MP) | Johnson & Johnson | Phase 2 | 27 |